Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates
about
Appraisal of Laparoscopic Liver Resection in the Treatment of Liver Metastasis with Special Reference to Outcome in Colorectal MalignanciesRole of contrast-enhanced ultrasonography in percutaneous radiofrequency ablation of liver metastases and efficacy evaluation.Contrast enhanced ultrasound: Roles in immediate post-procedural and 24-h evaluation of the effectiveness of thermal ablation of liver tumorsLocally ablative treatment of breast cancer liver metastases: identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study)Ki-67 is a prognostic biomarker of survival after radiofrequency ablation of liver malignanciesThermal ablation therapies in patients with breast cancer liver metastases: a review.Surgical management of breast cancer liver metastasesMetastatic Liver Disease: Indications for Locoregional Therapy and Supporting Data.Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy.Contrast-enhanced ultrasound in planning thermal ablation of liver metastases: Should the hypervascular halo be included in the ablation volume?().Radiofrequency ablation of metastatic lesions from breast cancer.Hepatic Resection or Ablation for Isolated Breast Cancer Liver Metastasis: A Case-control Study With Comparison to Medically Treated PatientsHepatic Radiofrequency Ablation-induced Stimulation of Distant Tumor Growth Is Suppressed by c-Met Inhibition.A comparison of laparoscopic radiofrequency ablation versus systemic therapy alone in the treatment of breast cancer metastasis to the liver.The role of radiofrequency ablation for treatment of metachronous isolated hepatic metastasis from colorectal cancerHepatic Thermal Ablation: Effect of Device and Heating Parameters on Local Tissue Reactions and Distant Tumor Growth.Percutaneous Thermal Ablation of Breast Cancer Metastases in Oligometastatic Patients.Clinical outcome of percutaneous RF-ablation of non-operable patients with liver metastasis from breast cancer.Comparison of four radiofrequency ablation systems at two target volumes in an ex vivo bovine liver model.Imaging to optimize liver tumor ablation.Aggressive treatment for hepatic metastases from breast cancer: results from a single center.Hepatic radiofrequency ablation: markedly reduced systemic effects by modulating periablational inflammation via cyclooxygenase-2 inhibition.Coagulation areas produced by cool-tip radiofrequency ablation and microwave ablation using a device to decrease back-heating effects: a prospective pilot study.Microwave ablation of liver malignancies: comparison of effects and early outcomes of percutaneous and intraoperative approaches with different liver conditions : New advances in interventional oncology: state of the art.Ultrasound-guided thermal radiofrequency ablation (RFA) as an adjunct to systemic chemotherapy for breast cancer liver metastases.
P2860
Q26781988-2495F37A-4553-4BC1-802E-FF7A7DAE5C2AQ30455429-768BC19E-22F7-462F-8ADF-67A570DC6FF4Q30533586-07761467-AFE9-4F3A-9E0D-D0954E53F735Q30657649-674DF452-2DA3-4BE3-A32D-D27B1CE68C28Q34003699-874D5491-1317-4D19-AC35-BCF0475E8865Q34445101-F99F5950-F627-4BFC-8231-32D55DD585A4Q34846333-27E3F52F-D715-420F-8E1D-7B4EEF6A2CCDQ36392298-7D184523-AC97-4AE8-AC78-DABEC0D46F4AQ36482781-A11D58A7-5FB6-4306-A6E0-4328A2E276BEQ36556708-0C43D5F0-CA41-4D83-B761-D88F44009A99Q36571156-C1D64ED7-FD90-43C2-9391-19D7080AA26CQ36757904-C5A868F7-7E96-4DD2-8B07-485C09691CF5Q36762751-AC165243-DF59-4A30-ACC2-108CD81D6A93Q37216654-FB9439A6-8CB1-4619-9187-A9F65F74D92DQ37605916-98E27CC0-4F11-4E56-92DD-E6712D903B38Q38412660-A8F2C71C-6D69-4958-9EAA-D4A33A5BEB67Q40919940-7CE7ED72-364A-4641-8E57-F938E2FD249BQ41603527-E6B020FC-8D0F-461D-B384-E798DB00104CQ42130170-283BD17D-01E4-4506-9AF6-5F3D85C7BB74Q42371266-220B8DA5-6DFD-4433-89F8-9C55D4D27D18Q42691061-F7556EC9-86C6-4F5B-9DD0-8B5A48F8DF0BQ45855021-EF6CB2B9-885B-49B8-B8D6-90E23EA5A2C5Q50800002-F84A7EFF-4CE4-4FA3-8E61-4AC1A7282F3BQ50881709-450064C7-9F01-4E47-8416-93A2EDD19D3EQ51454533-0FDA01FB-B5B3-4589-A020-6BB3050307F2
P2860
Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Breast cancer liver metastases ...... e and long-term survival rates
@ast
Breast cancer liver metastases ...... e and long-term survival rates
@en
type
label
Breast cancer liver metastases ...... e and long-term survival rates
@ast
Breast cancer liver metastases ...... e and long-term survival rates
@en
prefLabel
Breast cancer liver metastases ...... e and long-term survival rates
@ast
Breast cancer liver metastases ...... e and long-term survival rates
@en
P2093
P2860
P1433
P1476
Breast cancer liver metastases ...... e and long-term survival rates
@en
P2093
Anita Andreano
Fred T Lee
Maria Franca Meloni
Paul F Laeseke
Sandro Sironi
Tito Livraghi
P2860
P304
P356
10.1148/RADIOL.2533081968
P407
P577
2009-08-25T00:00:00Z